Alan O’Connell

In addition to the Shorla board, Alan also sits on the boards of Ario Pharma, Crescent Diagnostics and Fusion Pharmaceuticals. He previously sat on the boards of Prexton (acquired by Lundbeck), Veryan (acquired by Otsuka) and Xention (exited via pharma partnerships).